Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Idogen AB | 641,179 | net | 16 Jan 2023 | tx 5+641,179 |
| Medivir AB | 68,400 | net | 03 Feb 2021 | tx 5+68,400 |
| Elicera Therapeutics AB | 37,800 | net | 11 Mar 2025 | tx 4+37,800 |
| Ziccum | 33,000 | net | 01 Jun 2022 | tx 1+33,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Mar 2025 | PURCHASE | Elicera Therapeutics AB | 21,700 | 1.85 SEK | first after silence |
| 08 Mar 2024 | PURCHASE | Elicera Therapeutics AB | 3,100 | 16.20 SEK | first after silence |
| 16 Jan 2023 | PURCHASE | Idogen AB | 500,000 | 0.20 SEK | |
| 01 Jun 2022 | GRANT_AWARD | Ziccum | 33,000 | 0.00 SEK | deriv |
| 10 Feb 2022 | PURCHASE | Idogen AB | 16,500 | 3.06 SEK | first after silence |
| 11 Jun 2021 | GRANT_AWARD | Elicera Therapeutics AB | 6,500 | 8.00 SEK | |
| 11 Jun 2021 | GRANT_AWARD | Elicera Therapeutics AB | 6,500 | 0.00 SEK | deriv |
| 03 Feb 2021 | PURCHASE | Medivir AB | 5,000 | 7.00 SEK | deriv |
| 15 Jun 2020 | PURCHASE | Medivir AB | 50,000 | 1.30 SEK | deriv |
| 16 Mar 2020 | PURCHASE | Idogen AB | 92,000 | 0.60 SEK | first after silence |
| 05 Dec 2018 | PURCHASE | Idogen AB | 31,429 | 1.75 SEK | |
| 21 May 2018 | PURCHASE | Medivir AB | 3,400 | 5.63 SEK | |
| 20 Feb 2018 | PURCHASE | Medivir AB | 5,000 | 39.95 SEK | anomaly |
| 21 Jun 2017 | PURCHASE | Idogen AB | 1,250 | 42.00 SEK |
4 purchases reported after at least 12 months of silence — most recent on 11 Mar 2025.